In contrast, treated samples exhibited prominent interactions involving Middle and Universal tumor cells through pathways such as TIGIT-PVR, MDK-SDC4, and FN1-ITGA6/ITGB1, indicative of an adaptive tumor response characterized by increased immune checkpoint activity and extracellular matrix remodeling (Figure 4G). The gene discussed is PVR; the disease is neoplasm.